Segovia, Spain

Carmen Guerrero Benito


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Carmen Guerrero Benito: Pioneering Antiviral Polymers

Introduction:

Carmen Guerrero Benito, an esteemed inventor based in Segovia, Spain, is making strides in the field of polymer science. With a unique approach to developing materials that possess antiviral properties, she is contributing significantly to pharmaceutical advancements.

Latest Patents:

Carmen holds one patent titled "Process for obtaining polymers with antiviral activity." This innovative process focuses on synthesizing polymers that demonstrate antiviral activity while maintaining low toxicity levels. The patented process involves the reaction of molecules carrying specific functional groups in water or mixtures with water-miscible solvents, under controlled conditions. The end product is a polymeric material that boasts a molecular weight ranging from 1,500 to 100,000, making it suitable for both topical and systemic antiviral therapies in humans and animals.

Career Highlights:

Carmen has made her mark at Laboratorios Andromaco S.A., a company dedicated to advancing pharmaceutical solutions. Her work revolves around integrating cutting-edge science with practical applications, thus contributing to health and wellness through innovative polymeric materials.

Collaborations:

Throughout her career, Carmen has collaborated with esteemed colleagues, including Juan Pablo Pivel Ranieri and Antonio F. Guerrero Gomez-Pamo. These partnerships have allowed her to expand her research capabilities and enhance the development of antiviral polymers.

Conclusion:

Carmen Guerrero Benito is a noteworthy inventor whose work is shaping the future of antiviral therapies. Through her patented processes and collaborations, she continues to drive innovation in polymer science, promising improved treatment options for various viral infections. The impact of her inventions in the pharmaceutical sector is commendable and sets a precedent for future research in antiviral materials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…